Common oncogenic drivers of blood cancer, like MYC (17) or BCR-ABL1, are linked to centrosome amplification in experimental models, and in the latter case, p210 BCR-ABL1 is reportedly a centrosome-associated protein in chronic myeloid leukemia cells (18, 19). The gene discussed is MYC; the disease is hematopoietic and lymphoid system neoplasm.